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Introduction {#sec001}
============

*Acinetobacter baumannii* is now a recognised serious nosocomial pathogen and is isolated frequently particularly in intensive care unit settings where it is a cause of serious infections such as ventilator-associated pneumonia, wound and bloodstream infections \[[@pone.0179228.ref001]\]. It affects mainly severely debilitated patients and is typically selected by prior antimicrobial therapy \[[@pone.0179228.ref002]\]. *A*. *baumannii* shares several characteristics with methicillin-resistant *Staphylococcus aureus* (MRSA) such as multidrug resistance and long-term survival on inanimate surfaces such as computer keyboards, pillows, curtains and other dry surfaces. \[[@pone.0179228.ref002]--[@pone.0179228.ref004]\]. This longevity contributes to hospital outbreaks and the clonal spread of isolates, and it facilitates person-to-person transmission and environmental contamination. Strict adherence to infection control measures and sometimes even the closure of wards is required for the control of outbreaks \[[@pone.0179228.ref005]\].

Many typing methods have been used to investigate outbreaks of *A*. *baumannii*, and its clonal population structure is now well-established. Molecular typing of isolates obtained from various locations in the EU has shown the existence of three distinct clonal lineages that were termed pan-European clonal complexes I, II and III \[[@pone.0179228.ref006],[@pone.0179228.ref007]\]. Rep-PCR (DiversiLab) has shown that these lineages are no longer restricted to Europe and that there exist at least eight distinct international clonal lineages that are particularly associated with carbapenem-resistance \[[@pone.0179228.ref008]\]. Furthermore, multilocus sequence typing (MLST) has corroborated these data \[[@pone.0179228.ref009]--[@pone.0179228.ref011]\].

Pulsed-field gel electrophoresis (PFGE) is still considered the gold standard for outbreak analysis and although the method has been standardized, there is still the problem of reproducibility and portability of these data outside of reference laboratories \[[@pone.0179228.ref012]--[@pone.0179228.ref014]\]. Similarly, with rep-PCR we demonstrated that overlaying data generated from different centres is not reliable \[[@pone.0179228.ref015]\]. Perhaps the only truly portable established method is MLST, but this lacks the resolution for outbreak investigations \[[@pone.0179228.ref016]\].

With the advent of relatively cheap whole genome sequencing (WGS), there is now the possibility of comparing whole genomes and not relying on a few loci for typing purposes. There have been several studies that have addressed this by either comparing isolates on single nucleotide variants (SNVs) or genome-wide gene-by-gene allelic profiling, which is now termed core genome MLST (cgMLST) \[[@pone.0179228.ref017]--[@pone.0179228.ref020]\]. One barrier to the ready adoption of WGS for routine typing is the data analysis, which can be difficult for the non-bioinformatician. Therefore the development of user-friendly software is expected to greatly enhance the adoption of WGS \[[@pone.0179228.ref021],[@pone.0179228.ref022]\].

The objective of this study was to establish a cgMLST scheme for *A*. *baumannii* that can form the basis of a standardised nomenclature for typing this organism. To enable this, we first defined a core genome gene set that represented the genetic diversity of *A*. *baumannii* based on well-characterised reference strains from our collection and those available online. We then challenged the scheme against data available from NCBI. Well-defined outbreaks were sequenced and analysed to determine the scheme's suitability for outbreak investigations.

Material and methods {#sec002}
====================

Bacterial isolates and DNA extraction {#sec003}
-------------------------------------

For scheme calibration, a total of 53 carbapenem-susceptible and -resistant *A*. *baumannii* isolates from well-described hospital outbreaks occurring throughout Germany were used, some of which have been the subject of a previous report ([Table 1](#pone.0179228.t001){ref-type="table"}) \[[@pone.0179228.ref023]\]. The isolates had previously been assigned to international clones (IC) 1, 2, 4, 7, and 8 using rep-PCR, and their carbapenem resistance mechanisms determined by PCR \[[@pone.0179228.ref008],[@pone.0179228.ref011],[@pone.0179228.ref024]\]. Two isolates were not considered as clustering with the ICs. For the purpose of this study, an outbreak was defined as two or more isolates from a given hospital and from patients that were linked in time and space that had highly similar or identical PFGE patterns as had been determined previously. PFGE subtypes were defined as having 1--3 band differences. In some cases, there was more than one circulating clone in the same hospital. Isolates were routinely grown on blood agar and after overnight growth in LB liquid media, DNA was extracted using the MagAttract HMW DNA isolation kit following the manufacturer's instructions (Qiagen, Hilden, Germany) and quantified using the Qubit dsDNA BR assay (Fisher Scientific GmbH, Schwerte, Germany).

10.1371/journal.pone.0179228.t001

###### *A*. *baumannii* strains used for *A*. *baumannii* cgMLST cluster calibration.

![](pone.0179228.t001){#pone.0179228.t001g}

  Cluster   Strain     Hospital   City of Isolation   Year of Isolation   PFGE Type[^a^](#t001fn001){ref-type="table-fn"}   ST ('Oxford'/ 'Pasteur')   Clonal Lineage[^b^](#t001fn002){ref-type="table-fn"}   BAPS Partition                                   Carbapenem-resistance Determinant   Coverage (Assembled)   Contig Count (Assembled)   \% good cgMLST Genes   ENA Accession
  --------- ---------- ---------- ------------------- ------------------- ------------------------------------------------- -------------------------- ------------------------------------------------------ ------------------------------------------------ ----------------------------------- ---------------------- -------------------------- ---------------------- ---------------
  I         UKK_0008   3          Berlin              2006                2-A1                                              436/2                      IC2                                                    2                                                OXA-23                              108                    112                        99.8                   ERS1042999
  I         UKK_0012   3          Berlin              2006                2-A1                                              436/2                      IC2                                                    2                                                OXA-23                              98                     107                        99.8                   ERS1043003
  I         UKK_0016   3          Berlin              2006                2-A1                                              436/2                      IC2                                                    2                                                OXA-23                              99                     160                        99.7                   ERS1043004
  I         UKK_0024   3          Berlin              2006                not done                                          436/2                      IC2                                                    2                                                OXA-23                              114                    130                        99.7                   ERS1043005
  I         UKK_0031   3          Berlin              2006                2-A1                                              436/2                      IC2                                                    2                                                OXA-23                              116                    102                        99.8                   ERS1043006
  I         UKK_0038   3          Berlin              2006                2-A2                                              436/2                      IC2                                                    2                                                OXA-23                              109                    99                         99.8                   ERS1043007
  I         UKK_0047   3          Berlin              2006                2-A1                                              436/2                      IC2                                                    2                                                OXA-23                              94                     145                        99.8                   ERS1043008
  I         UKK_0052   3          Berlin              2006                2-A1                                              436/2                      IC2                                                    2                                                OXA-23                              74                     123                        99.8                   ERS1043009
  II        UKK_0252   8          Leverkusen          2011                4-A                                               218/2                      IC2                                                    2                                                OXA-23                              56                     71                         99.8                   ERS1043096
  II        UKK_0254   8          Leverkusen          2011                4-A                                               218/2                      IC2                                                    2                                                OXA-23                              104                    121                        99.7                   ERS1043128
  II        UKK_0260   8          Leverkusen          2011                4-A                                               218/2                      IC2                                                    2                                                OXA-23                              116                    178                        99.8                   ERS1043151
  II        UKK_0263   8          Leverkusen          2011                4-A                                               218/2                      IC2                                                    2                                                OXA-23                              37                     75                         99.7                   ERS1043152
  II        UKK_0266   8          Leverkusen          2012                4-A                                               218/2                      IC2                                                    2                                                OXA-23                              92                     67                         99.9                   ERS1043178
  III       UKK_0253   8          Leverkusen          2011                4-B                                               195/2                      IC2                                                    2                                                OXA-23                              118                    157                        99.7                   ERS1043117
  III       UKK_0255   8          Leverkusen          2011                4-B                                               195/2                      IC2                                                    2                                                OXA-23                              119                    108                        99.9                   ERS1043139
  III       UKK_0256   8          Leverkusen          2011                4-B                                               195/2                      IC2                                                    2                                                OXA-23                              119                    183                        99.7                   ERS1043150
  III       UKK_0264   8          Leverkusen          2011                4-B                                               195/2                      IC2                                                    2                                                OXA-23                              73                     140                        99.7                   ERS1043177
  IV        UKK_0173   5          Cologne             2011                6A                                                558/2                      IC2                                                    2                                                no                                  119                    120                        99.6                   ERS1043040
  IV        UKK_0174   5          Cologne             2011                6A                                                558/2                      IC2                                                    2                                                no                                  113                    104                        99.6                   ERS1043042
  IV        UKK_0177   5          Cologne             2011                6A                                                558/2                      IC2                                                    2                                                no                                  117                    159                        99.6                   ERS1043043
  V         UKK_0178   5          Cologne             2011                6-B                                               448/2                      IC2                                                    admixture                                        OXA-23                              102                    178                        99.3                   ERS1043044
  V         UKK_0179   5          Cologne             2011                6-B                                               448/2                      IC2                                                    admixture                                        OXA-23                              79                     159                        99.2                   ERS1043045
  V         UKK_0180   5          Cologne             2011                6-B                                               448/2                      IC2                                                    admixture                                        OXA-23                              116                    276                        99.2                   ERS1043057
  VI        UKK_0182   6          Cologne             2011                7-A1                                              448/2                      IC2                                                    admixture                                        OXA-23                              123                    147                        99.3                   ERS1043059
  VI        UKK_0183   6          Cologne             2011                7-A2                                              448/2                      IC2                                                    admixture                                        OXA-23                              124                    156                        99.0                   ERS1043089
  VI        UKK_0185   6          Cologne             2011                7-A1                                              448/2                      IC2                                                    admixture                                        OXA-23                              124                    142                        99.2                   ERS1043090
  VI        UKK_0193   6          Cologne             2011                7-A2                                              448/2                      IC2                                                    admixture                                        OXA-23                              122                    123                        99.2                   ERS1043092
  VI        UKK_0196   6          Cologne             2011                7-A2                                              448/2                      IC2                                                    admixture                                        OXA-23                              98                     153                        99.2                   ERS1043093
  VII       UKK_0056   2          Berlin              2007                1-B                                               350/2                      IC2                                                    2                                                OXA-58                              69                     70                         99.9                   ERS1043010
  VII       UKK_0057   2          Berlin              2007                1-B                                               350/2                      IC2                                                    2                                                OXA-58                              67                     78                         99.9                   ERS1043029
  VII       UKK_0058   2          Berlin              2007                1-B                                               350/2                      IC2                                                    2                                                OXA-58                              64                     75                         99.9                   ERS1043030
  VIII      UKK_0004   3          Berlin              2005                2-B                                               438/15                     IC4                                                    4                                                OXA-58                              116                    95                         99.4                   ERS1042932
  VIII      UKK_0005   3          Berlin              2005                2-B                                               438/15                     IC4                                                    4                                                OXA-58                              111                    118                        99.3                   ERS1042933
  VIII      UKK_0006   3          Berlin              2005                2-B                                               438/15                     IC4                                                    4                                                OXA-58                              114                    142                        99.2                   ERS1042934
  VIII      UKK_0007   3          Berlin              2005                2-B                                               438/15                     IC4                                                    4                                                OXA-58                              116                    124                        99.1                   ERS1042935
  IX        UKK_0412   9          Ludwigshafen        2013                8-A                                               933/94                     IC1                                                    not done[^d^](#t001fn004){ref-type="table-fn"}   OXA-23                              117                    104                        99.1                   ERS1043424
  IX        UKK_0413   9          Ludwigshafen        2013                8-A                                               933/94                     IC1                                                    not done                                         OXA-23                              57                     150                        99.2                   ERS1043425
  IX        UKK_0414   9          Ludwigshafen        2013                8-A                                               933/94                     IC1                                                    not done                                         OXA-23                              104                    155                        99.1                   ERS1043426
  IX        UKK_0415   9          Ludwigshafen        2014                8-A                                               933/94                     IC1                                                    1C                                               OXA-23                              101                    173                        99.1                   ERS1043427
  X         UKK_0283   1          Aachen              2010                9-A1                                              229/25                     IC7                                                    1A                                               OXA-23                              59                     141                        99.2                   ERS1043179
  X         UKK_0284   1          Aachen              2010                9-A1                                              229/25                     IC7                                                    1A                                               OXA-23                              113                    80                         99.2                   ERS1043215
  X         UKK_0285   1          Aachen              2011                9-A2                                              229/25                     IC7                                                    1A                                               OXA-23                              104                    96                         99.2                   ERS1043216
  X         UKK_0286   1          Aachen              2011                9-A2                                              229/25                     IC7                                                    1A                                               OXA-23                              58                     186                        99.1                   ERS1043217
  X         UKK_0290   1          Aachen              2011                not done                                          229/25                     IC7                                                    1A                                               OXA-23                              115                    100                        98.2                   ERS1043218
  X         UKK_0295   1          Aachen              2011                not done                                          229/25                     IC7                                                    1A                                               OXA-23                              98                     91                         99.2                   ERS1043219
  XI        UKK_0386   4          Bonn                2013                10-A                                              229/25                     IC7                                                    1A                                               OXA-23                              110                    125                        99.0                   ERS1043422
  XI        UKK_0409   4          Bonn                2013                10-A                                              229/25                     IC7                                                    1A                                               OXA-23                              93                     79                         99.1                   ERS1043423
  XII       UKK_0306   9          Ludwigshafen        2012                8-B1                                              1118/136                   unc[^c^](#t001fn003){ref-type="table-fn"}              not done                                         no                                  58                     90                         99.0                   ERS1043220
  XII       UKK_0318   9          Ludwigshafen        2012                8-B2                                              1118/136                   unc                                                    not done                                         no                                  95                     333                        99.0                   ERS1043221
  XIII      UKK_0333   7          Cologne             2013                11-A                                              391/157                    IC8                                                    1C                                               OXA-23                              68                     194                        98.8                   ERS1043342
  XIII      UKK_0334   7          Cologne             2012                11-A                                              391/157                    IC8                                                    1C                                               OXA-23                              59                     93                         98.8                   ERS1043375
  XIII      UKK_0368   7          Cologne             2013                11-A                                              391/157                    IC8                                                    1C                                               OXA-23                              53                     103                        98.7                   ERS1043384
  XIII      UKK_0369   7          Cologne             2013                11-A                                              391/157                    IC8                                                    1C                                               OXA-23                              87                     100                        98.7                   ERS1043385

^a^PFGE types: The first numeral indicates the hospital, the letter is for pulsotype which is specific to that hospital, and in some cases there is a second numeral for subtype.

^b^Clonal lineage based on rep-PCR clustering.

^c^unc; unclassified as it did not cluster with one of the ICs.

^d^STs above ST920 were not available when BAPS analysis was performed, therefore not included in BAPS partitioning.

Whole genome sequencing and assembly {#sec004}
------------------------------------

Sequencing libraries were prepared using the Nextera XT library prep kit (Illumina GmbH, Munich, Germany) for a 250bp paired-end sequencing run on an Illumina MiSeq sequencer. Samples were sequenced to aim for a minimum 100-fold coverage using Illumina's recommended standard protocols with dual-index barcoding and rotation of barcodes over time. Sequencing run quality (Q30 and output) had to fulfill the manufacturer's minimum specifications. The resulting FASTQ files were quality trimmed and assembled *de novo* using the Velvet assembler that is integrated in Ridom SeqSphere^+^ v.3.0 software (Ridom GmbH, Münster, Germany) \[[@pone.0179228.ref025]\]. Here, reads were trimmed at their 5\'- and 3\'-ends until an average base quality of 30 was reached in a window of 20 bases, and the assembly was performed with Velvet version 1.1.04 \[[@pone.0179228.ref026]\] using optimized k-mer size and coverage cutoff values based on the average length of contigs with \> 1000 bp.

BAPS {#sec005}
----

To determine the overall *A*. *baumannii* species variation, we applied a Bayesian analysis of population structure (BAPS) \[[@pone.0179228.ref027]\] with the more discriminatory MLST scheme described by Bartual et al \[[@pone.0179228.ref028]\]. All MLST profiles available as of March 25^th^ 2015 (913 sequence types \[ST\]) were downloaded from the PubMLST web site (<http://pubmlst.org/abaumannii/>), all allelic gene sequences per locus were multiple aligned using MUSCLE \[[@pone.0179228.ref029]\] and finally concatenated for each ST. The BAPS analysis was carried out using the clustering of linked molecular data functionality. Ten runs were performed setting an upper limit of 20 partitions. Admixture analysis was performed using the following parameters: minimum population size considered 5, iterations 50, number of reference individuals simulated from each population 50, number of iterations for each reference individual 10. Those STs that had significant (*P*\< 0.05) admixture were not assigned to a partition. The aligned and concatenated ST sequences were used to produce a maximum likelihood (ML) tree using FastTree 2 \[[@pone.0179228.ref030]\]. Finally, the assignment of sequence types to BAPS partitions was visualized by coloring the nodes (representing the individual STs) of the radial phylogram calculated with FastTree 2 that was drawn by Dendroscope 3 \[[@pone.0179228.ref031]\]. The largest resulting partition was further subdivided by visual inspection of the phylogram.

cgMLST target gene definition {#sec006}
-----------------------------

To determine the cgMLST gene set, a genome-wide gene-by-gene comparison was performed using the cgMLST target definer (version 1.1) function of the SeqSphere^+^ (Ridom GmbH, Münster, Germany) software with default parameters as described previously \[[@pone.0179228.ref017]\]. The ACICU strain served as reference genome (NC_010611.1, dated 12 August 2015) \[[@pone.0179228.ref032]\]. BLAST version 2.2.12 was used for pairwise comparison with the *A*. *baumannii* query genomes ([Table 2](#pone.0179228.t002){ref-type="table"}).

10.1371/journal.pone.0179228.t002

###### List of *A*. *baumannii* strains and genomes used for cgMLST *A*. *baumannii* target definition.

![](pone.0179228.t002){#pone.0179228.t002g}

  Strain              Lineage   BAPS Partition                                   NCBI Genome Status   ST 'Oxford'   ST 'Pasteur'   Avg. Coverage (Assembled)   NCBI/ENA Accession
  ------------------- --------- ------------------------------------------------ -------------------- ------------- -------------- --------------------------- --------------------
  ACICU (Reference)   IC2       2                                                Complete Genome      437           2              n/a                         NC_010611.1
  AYE                 IC1       4                                                Complete Genome      231           1              n/a                         NC_010410.1
  AC30                IC2       2                                                Complete Genome      195           2              245.0                       CP007577.1
  NIPH 1669           IC3       4                                                Scaffold             106           3              139.0                       APOQ01
  UKK_0004            IC4       4                                                This study           438           15             113.0                       ERS1042932
  TG02011             IC5       1C                                               Contig               205           79             79.0                        ASES01
  BMBF-448            IC6       not done[^a^](#t002fn002){ref-type="table-fn"}   This study           944           78             76.0                        ERS1047685
  1429530             IC7       1A                                               Contig               229           25             113.3                       JEWM01
  LAC-4               IC8       4                                                Complete Genome      447           10             116.0                       NZ_CP007712.1
  NIPH 601            n/a       1B                                               Scaffold             373           40             86.0                        APQZ01
  AA-014              n/a       1D                                               Contig               499           158            63.9                        AMGA01
  6013150             n/a       1E                                               Scaffold             498           81             59.8                        ACYQ02
  268680              n/a       6                                                Contig               355           16             95.2                        JEYN01

n/a: not available

^a^STs above ST920 were not available when BAPS analysis was performed, therefore not included in BAPS partitioning

Evaluation and calibration of the cgMLST target gene set {#sec007}
--------------------------------------------------------

To evaluate the newly defined cgMLST scheme, all available *A*. *baumannii* NCBI genome datasets (as of 2016-08-29) were downloaded, analyzed with the cgMLST and the 'Oxford' and 'Pasteur' MLST schemes, and filtered by ST. Also NCBI data that were used as reference or query genomes for scheme definition were removed. It was assumed that a suitable cgMLST scheme should reach on average at least 97.5% cgMLST called targets for all of those quality-filtered genomes. In addition, genome data for the three closely related species from the ACB complex, i.e. *A*. *nosocomialis*, *A*. *pittii*, and *A*. *calcoaceticus* were added for demonstration of the applicability of the defined cgMLST scheme for *A*. *baumannii* sensu stricto only.

To further calibrate the *A*. *baumannii* cgMLST scheme to investigate outbreaks, 53 sequenced carbapenem-resistant isolates were analysed using Ridom SeqSphere^+^ software to determine the presence of the target genes. Again we assumed that a well-defined core genome would cover at least 97.5% of the cgMLST genes used in this scheme. The target genes were extracted as previously described with "required identity to reference sequence of 90%", "required aligned to reference sequence with 100%" \[[@pone.0179228.ref017]\] and the process included an assessment of the quality of the target genes, i.e. the absence of frame shifts and ambiguous nucleotides. A core genome gene was considered a "good target" only if all of the above criteria were met, in which case the complete sequence was analyzed in comparison to the ACICU reference. Alleles for each gene were called and assigned automatically by the SeqSphere^+^ software to ensure unique nomenclature. The combination of all alleles in each strain formed an allelic profile that was used to generate minimum spanning trees (MST) using the parameter "pairwise ignore missing values" during distance calculation. The MST was used to determine if outbreak isolates could be attributed to the same cluster and clearly separated from other clusters. To maintain backwards compatibility, classical MLST alleles (Oxford and Pasteur schemes) were extracted from the assembled genomes with SeqSphere^+^ using the PubMLST nomenclature (<http://pubmlst.org/>).

Results {#sec008}
=======

Species variability was checked by BAPS analysis based on 913 'Oxford' MLST ST which resulted in 8 partitions with ST 262 being the only member of BAPS partition 8. From the remaining 912 analysed STs, 312 showed significant admixture (*P*\> 0.05) and were removed from the analysis, and 600 STs could be grouped into 7 partitions with a probability of ≥ 0.95 ([S1 Table](#pone.0179228.s002){ref-type="supplementary-material"}). Members of the largest partition 1 were located at five distinct branches of the ML tree, therefore this partition was further subdivided manually into five subgroups according to the branching of the tree (Partition 1A -- 1E) ([S1 Fig](#pone.0179228.s001){ref-type="supplementary-material"}). For BAPS partitions 5 and 7 no strains, genomic data, or taxonomic information were available neither from NCBI or PubMLST. Strain data of BAPS partitions 3 and 8 were not considered for core genome genes definition because all known isolates of these groups were taxonomically identified as *A*. *nosocomialis*. Members from the remaining BAPS partitions and eight international clone lineages were included as query genomes for core genome definition ([Table 2](#pone.0179228.t002){ref-type="table"}).

Based on these data the cgMLST Target Definer created a cgMLST scheme comprising 2,390 targets of the ACICU reference genome (58.6% of the complete genome) ([S2 Table](#pone.0179228.s003){ref-type="supplementary-material"}). A total of 1,573 *A*. *baumannii* datasets could be downloaded from NCBI Genomes and used. Genome data for which no MLST ST ('Oxford' and/or 'Pasteur') could be extracted were removed. Furthermore, the ST information was used to remove wrongly as *A*. *baumannii* identified genomes (e.g., *A*. *nosocomialis*). Thereby, in total 1,339 *A*. *baumannii* genomes were used to challenge the newly defined cgMLST scheme. On average 98.4% cgMLST genes were called successfully for those genomes. Analysis of datasets from the closely related species *A*. *nosocomialis*, *A*. *pittii*, and *A*. *calcoaceticus* resulted in 71.2%, 33.3%, and 23.2% good targets, respectively, thus demonstrating the applicability of the defined cgMLST scheme for *A*. *baumannii* sensu stricto only ([S3 Table](#pone.0179228.s004){ref-type="supplementary-material"}).

Fifty-three *A*. *baumannii* genomes were sequenced from isolates which were collected from patients hospitalized in nine hospitals located in eight German cities between 2005--2013. A summary of the genome assembly is shown in [Table 1](#pone.0179228.t001){ref-type="table"}. Average coverage ranged from 37- to 124-fold, with a median of 102-fold. The number of contigs ranged from 67--333, with a median of 123. The percentage of good targets based on the core genome ranged from 98.7%−99.9% with a median of 99.3%.

There was a good correlation between PFGE types and cgMLST clusters. Based on their cgMLST profiles ([S4 Table](#pone.0179228.s005){ref-type="supplementary-material"}), a minimum spanning tree was generated ([Fig 1](#pone.0179228.g001){ref-type="fig"}). Fifty-three isolates were grouped into 13 distinct clusters (I to XIII, [Table 1](#pone.0179228.t001){ref-type="table"}). Within a cluster, there were several examples where isolates were identical within the same hospital outbreak (clusters V, VI and IX), ≤ 5 differences (clusters I, II, IV, VII, VIII, XI, XII, XIII) and ≥ 5 differences (III andX,). Clusters IV and V contained isolates from the same hospital that were isolated within a 5-week period. However, although they shared the same Pasteur sequence type (ST2) and were double locus variants (DLV) using the Oxford scheme, they differed in 497 alleles. The number of allelic differences did not correlate with length of outbreak. For example isolate UKK_0255 from cluster III was collected on the same day as UKK_0253 and UKK_0256 but differed by 8 alleles, while cluster VI isolates were collected over a 5-week period and were identical.

![Minimum spanning tree based on cgMLST allelic profiles of 53 *A*. *baumannii* isolates.\
Each circle represents an allelic profile based on sequence analysis of 2,390 cgMLST target genes. The numbers on the connecting lines illustrate the numbers of target genes with different alleles. Colours of the circles represent the different isolation sources. Closely related genotypes (≤10 alleles difference) are shaded and clusters are numbered consecutively (I to XIII). Isolates belonging to the same IC lineage are surrounded by dotted circles.](pone.0179228.g001){#pone.0179228.g001}

The cgMLST clustering also matched the classification of international clones as previously determined by DiversiLab typing or MLST. The investigated outbreaks included strains that we determined to belong to IC1, IC2, IC4, IC7, IC8, and one set of strains that were not part of these clonal lineages ([Fig 1](#pone.0179228.g001){ref-type="fig"}). Clusters I-VII had up to 507 differences within IC2, but had \>2000 differences to clusters belonging to other lineages.

Discussion {#sec009}
==========

For the thorough investigation of hospital outbreaks of bacterial infections, especially in the globalised society we now live in, simple, accurate and portable typing methods are essential. Thus, the ability to determine clonality among bacterial strains and to share this information in a centralised database has many advantages. MLST can be considered the proof of principle of a sequence-based method with a curated and standardised nomenclature \[[@pone.0179228.ref033]\]. However classical MLST does not have the resolution to determine person-person spread \[[@pone.0179228.ref016]\]. More discriminatory DNA fingerprinting methods such as PFGE and rep-PCR (DiversiLab) are not always comparable between different laboratories \[[@pone.0179228.ref015]\]. The use of WGS and user-friendly software means that whole genomes can be sequenced and compared within a few working days \[[@pone.0179228.ref017]\]. In our present study, we demonstrated that our *A*. *baumannii* cgMLST scheme was able to distinguish different outbreaks from the same hospital which shared the same or similar MLST profiles. An additional result was that we were clearly able to distinguish between different international *A*. *baumannii* clones.

Although there are now a plethora of sequenced *A*. *baumannii* genomes, few outbreaks have been investigated by WGS, and where applied to outbreak analysis, all the studies have performed SNV analysis, whereas our approach was allele-based \[[@pone.0179228.ref034]--[@pone.0179228.ref037]\]. In all of these cases, the SNV approach was compared to PFGE and was found to be generally in accordance with a few exceptions. For example, Salipante et al reported discrepancies between PFGE and WGS \[[@pone.0179228.ref036]\]. Halachev et al. applied SNV analysis during a prolonged *A*. *baumannii* outbreak and was able to differentiate between outbreak and non-outbreak strains and when combined with epidemiological data was able to reconstruct potential transmissions \[[@pone.0179228.ref037]\]. The ability to differentiate between different *A*. *baumannii* clonal lineages was also investigated and a threshold of 2,500 core SNPs was determined to accurately distinguish isolates from different clonal lineages \[[@pone.0179228.ref035]\]. In our study, we found that there were in the order of approximately 2000 allelic differences between different clonal lineages.

However, SNV analysis has to be carefully analysed and a common nomenclature may be difficult to adopt as there are multiple variations at the genome level both in ORFs and intergenic regions. Furthermore, during infection, several studies have shown that SNVs can develop rapidly and are often associated with antibiotic resistance determinants \[[@pone.0179228.ref038],[@pone.0179228.ref039]\]. Indeed, Halachev et al. found several SNVs in *pmrB* which was associated with reduced susceptibility to colistin. Our cgMLST scheme does not follow the SNV approach, instead we have opted for an allele-based method. This has the advantage that it can "soften" the conflicting signals of horizontal-gene transfer such as a bias introduced by a single homologous recombination in a gene that typically results in multiple SNVs but only in single allele change. A further advantage of our allele-based typing is its relatively easy storage and curation in a centralised database, similar that seen with classical MLST \[[@pone.0179228.ref016],[@pone.0179228.ref040]\]. To date, cgMLST schemes using the Ridom SeqSphere^+^ software have been established with *Listeria monocytogenes*, *Staphylococcus aureus*, *Legionella pneumophila*, *Francisella tularensis*, and *Mycobacterium tuberculosis* \[[@pone.0179228.ref017],[@pone.0179228.ref041]--[@pone.0179228.ref044]\].

Bacterial genomes show high diversity and this makes the definition of a core-genome difficult. Previous work has shown that there are eight international *A*. *baumannii* clonal lineages. Of these, IC2 is the most prevalent clone worldwide and indeed is responsible for the majority of outbreaks \[[@pone.0179228.ref008],[@pone.0179228.ref011]\]. Therefore, we took the approach that the core genome should be built around an IC2 isolate, which was why ACICU strain was chosen. From a genome of 3972 ORFs (ACICU genome), we determined that the core genome was made up of 2,390 genes. Based on the strains that we investigated, the number of missing targets was very small, the maximum was always below \<2.5% of total targets. Some of these missing targets are caused by the presence of IS elements that insert into genes. These IS elements can be present in multiple copies and are one of the reasons for genome misassembly and multiple contigs \[[@pone.0179228.ref045]\].

In conclusion, we present a highly representative and discriminatory cgMLST scheme for WGS-based typing of *A*. *baumannii*. We were able to differentiate between strains obtained from patients at the same hospital and to link isolates from patients hospitalized in different cities. Easy to use software and public nomenclature will be the key for wide-spread adoption and contribution to outbreak analysis and general epidemiological surveillance.
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###### Partitions as determined by BAPS mapped on to a radial phylogram generated by FastTree 2.

\(A\) Overview and (B) Zoom into the central part of the tree. BAPS partition 1 was further subdivided manually into five subgroups (1A-1E) according to the branching of the tree. STs that have significant admixture are colored in black.
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